BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 2270988)

  • 1. [The morphological diagnosis of malignant non-Hodgkin's lymphomas (lymphosarcomas)].
    Probatova NA
    Arkh Patol; 1990; 52(9):72-5. PubMed ID: 2270988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [R.E.A.L. classification of non-Hodgkin lymphoma from the clinico-oncologic viewpoint].
    Meusers P; Brittinger G
    Praxis (Bern 1994); 1998 Jun; 87(23):793-800. PubMed ID: 9654985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fas ligand expression in nodal non-Hodgkin's lymphoma.
    Müllauer L; Mosberger I; Chott A
    Mod Pathol; 1998 Apr; 11(4):369-75. PubMed ID: 9578088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Paraneoplastic lymphadenopathy].
    Melikian AL; Nikitin EA; Kaplanskaia IB; Frank GA
    Ter Arkh; 2007; 79(8):44-52. PubMed ID: 17926471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of CD95 antigen and Bcl-2 protein in non-Hodgkin's lymphomas and Hodgkin's disease.
    Nguyen PL; Harris NL; Ritz J; Robertson MJ
    Am J Pathol; 1996 Mar; 148(3):847-53. PubMed ID: 8774139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Practical value of the histopathological diagnosis of malignant lymphomas].
    Bryon PA
    Rev Prat; 1993 Sep; 43(13):1617-23. PubMed ID: 8303176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The results of histological and immunohistological studies of primary biopsies in 400 patients with non-Hodgkin's lymphoma in the North-West region of Russia (according to WHO classification)].
    Krivolapov IuA
    Ter Arkh; 2004; 76(7):64-70. PubMed ID: 15379131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preferential expression of the mucosal homing receptor integrin alpha 4 beta 7 in gastrointestinal non-Hodgkin's lymphomas.
    Drillenburg P; van der Voort R; Koopman G; Dragosics B; van Krieken JH; Kluin P; Meenan J; Lazarovits AI; Radaszkiewicz T; Pals ST
    Am J Pathol; 1997 Mar; 150(3):919-27. PubMed ID: 9060830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nodal monocytoid B-cell lymphoma (nodal marginal-zone B-cell lymphoma).
    Nathwani BN; Drachenberg MR; Hernandez AM; Levine AM; Sheibani K
    Semin Hematol; 1999 Apr; 36(2):128-38. PubMed ID: 10319381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Malignant lymphoma with medium-sized macronucleolated cells in the dog: involvement of an original cell from the marginal zone of the reactive lymph node].
    Magnol JP; Fournel C; Marchal T; Chabanne L; Bryon PA; Felman P
    Bull Acad Natl Med; 1995 Jan; 179(1):51-65. PubMed ID: 7788447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New REAL clinical entities.
    Fisher RI; Miller TP; Grogan TM
    Cancer J Sci Am; 1998 Jul; 4 Suppl 2():S5-12. PubMed ID: 9672769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paraffin-immunohistochemical analysis of 226 non-Hodgkin's malignant lymphomas in the endemic area of human T-cell leukemia virus type 1.
    Hasui K
    Acta Pathol Jpn; 1991 May; 41(5):350-62. PubMed ID: 1867099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD40 ligand is constitutively expressed in a subset of T cell lymphomas and on the microenvironmental reactive T cells of follicular lymphomas and Hodgkin's disease.
    Carbone A; Gloghini A; Gruss HJ; Pinto A
    Am J Pathol; 1995 Oct; 147(4):912-22. PubMed ID: 7573367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CDK9/CYCLIN T1 expression during normal lymphoid differentiation and malignant transformation.
    Bellan C; De Falco G; Lazzi S; Micheli P; Vicidomini S; Schürfeld K; Amato T; Palumbo A; Bagella L; Sabattini E; Bartolommei S; Hummel M; Pileri S; Tosi P; Leoncini L; Giordano A
    J Pathol; 2004 Aug; 203(4):946-52. PubMed ID: 15258998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A morphological study of 608 cases of canine malignant lymphoma in France with a focus on comparative similarities between canine and human lymphoma morphology.
    Ponce F; Marchal T; Magnol JP; Turinelli V; Ledieu D; Bonnefont C; Pastor M; Delignette ML; Fournel-Fleury C
    Vet Pathol; 2010 May; 47(3):414-33. PubMed ID: 20472804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary non-Hodgkin lymphomas of the CNS. Classification, tissue reaction and proliferative activity.
    Bergmann M; Kuchelmeister K; Edel G; Heinecke A
    Zentralbl Pathol; 1993 Mar; 139(1):37-44. PubMed ID: 8098955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological markers in non-Hodgkin's lymphomas.
    Gobbi M; Mazza P; Mantovani W; Fiacchini M; Lauria F; Tura S
    Boll Ist Sieroter Milan; 1979 Nov; 58(5):410-5. PubMed ID: 399843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical typing of non-Hodgkin's lymphoma-comparing working formulation and WHO classification.
    Kalyan K; Basu D; Soundararaghavan J
    Indian J Pathol Microbiol; 2006 Apr; 49(2):203-7. PubMed ID: 16933715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromosomal abnormalities and molecular genetics of non-Hodgkin's lymphoma.
    Ong ST; Le Beau MM
    Semin Oncol; 1998 Aug; 25(4):447-60. PubMed ID: 9728595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytologic and immunocytologic studies of peripheral T-cell lymphomas.
    Oertel J; Oertel B; Lobeck H; Huhn D
    Acta Cytol; 1991; 35(3):285-93. PubMed ID: 2042431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.